🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Glycorex Transplantation AB (publ) (NGM:GTAB.B)
Sweden flag Sweden · Delayed Price · Currency is SEK
1.755
-0.015 (-0.85%)
At close: Nov 18, 2026

NGM:GTAB.B Income Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
34.4338.8435.1629.9636.1228.2
Revenue
34.4338.8435.1629.9636.1228.2
Revenue Growth
-8.87%10.48%17.34%-17.04%28.06%3.55%
Cost of Revenue
7.046.86.943.65.843.95
Gross Profit
27.3932.0428.2226.3730.2724.26
Selling, General & Admin
30.9230.0829.3436.9432.3129.23
Amortization of Goodwill & Intangibles
3.423.423.423.423.683.76
Other Operating Expenses
-0.35-0.27-0.02-1.57-2.24-1.66
Operating Expenses
39.5639.1138.6444.3238.6336.07
Operating Income
-12.17-7.07-10.42-17.95-8.36-11.82
Interest Expense
-0.31-0.36-0.58-0.29-0.25-0.27
Interest & Investment Income
0.040.040.150.30.020.01
Currency Exchange Gain (Loss)
-0.33-0.39-0.16-0.030.06-0.16
EBT Excluding Unusual Items
-12.78-7.78-11-17.98-8.52-12.24
Asset Writedown
----12.39--
Pretax Income
-12.78-7.78-11-30.36-8.52-12.24
Income Tax Expense
-0.06-0.06-0.06-0.060
Net Income
-12.72-7.72-10.94-30.36-8.58-12.24
Net Income to Common
-12.72-7.72-10.94-30.36-8.58-12.24
Net Income Growth
------
Shares Outstanding (Basic)
797874747474
Shares Outstanding (Diluted)
797874747474
Shares Change
3.55%5.93%---0.36%
EPS (Basic)
-0.16-0.10-0.15-0.41-0.12-0.17
EPS (Diluted)
-0.16-0.10-0.15-0.41-0.12-0.17
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
0.262.360.1-12.53-1.48-2.56
Free Cash Flow Per Share
0.000.030.00-0.17-0.02-0.04
Gross Margin
79.55%82.48%80.27%88.00%83.82%86.00%
Operating Margin
-35.35%-18.19%-29.63%-59.92%-23.14%-41.89%
Profit Margin
-36.94%-19.87%-31.12%-101.34%-23.75%-43.41%
Free Cash Flow Margin
0.75%6.07%0.29%-41.81%-4.10%-9.08%
EBITDA
-11.78-6.4-9.78-17.45-7.84-11.46
EBITDA Margin
-34.20%-16.46%-27.81%-58.22%-21.69%-40.65%
D&A For EBITDA
0.40.670.640.510.520.35
EBIT
-12.17-7.07-10.42-17.95-8.36-11.82
EBIT Margin
-35.35%-18.19%-29.63%-59.92%-23.14%-41.89%
Revenue as Reported
35.7940.1134.7733.439.3329.58